MYLAN P157 (Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg (base))

Pill imprint MYLAN P157 has been identified as Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg (base).

Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 850 mg / 15 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Metformin hydrochloride and pioglitazone hydrochloride

Imprint:

MYLAN P157

Strength:

850 mg / 15 mg (base)

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Antidiabetic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.